Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2004 March;70(3) > Minerva Anestesiologica 2004 March;70(3):97-107

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

ORIGINAL ARTICLES  ANESTHESIA Freefree

Minerva Anestesiologica 2004 March;70(3):97-107

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English, Italian

Tranexamic acid in primary CABG surgery: high vs low dose

Armellin G., Vinciguerra A., Bonato R., Pittarello D., Giron G. P.

Anesthesiology and Resuscitation Section Department of Pharmacology and Anesthesiology “Egidio Meneghetti” University of Padua, Padua, Italy


PDF


Aim. Prophylactic administration of tranexamic acid decreases bleeding and transfusions after cardiac procedures but it is still unclear what the best dose and the most appropriate timing to get the best results are.
Methods. We enrolled 250 patients scheduled for elective, primary coronary revascularization. They were randomly divided into 2 groups. Group H received tranexamic 30 mg kg-1 soon after the induction of anaesthesia and a further same dose was added to the prime solution of cardiopulmonary bypass (CPB). Group L received tranexamic acid 15 mg kg-1 after systemic heparinization followed by an infusion of 1 mg kg-1 h-1 till the end of the operation. Transfusions of bank blood products, bleeding in the postoperative period and coagulation profile were recorded.
Results. We did not find any difference between the groups either with respect to transfusion requirements or with respect to blood loss.
Conclusion. For elective, first time coronary artery bypass surgery, both dosages of tranexamic acid are equally effective. Theoretically, it seems safer to administer it when patients are protected from thrombus formation by full heparinization.

top of page